Notice of Intent to Sole Source to Life Technologies Corporation Tender, USA - 86840906

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source to Life Technologies Corporation

Deadline : 10 Aug 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 86840906

Document Ref. No. : 2023-76751

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Government proposes to make an award to Life Technologies Corporation for the purchase of custom TaqMan Array cards (product ID 4485460 special gene-ex, conf(4), quantity 700 from Thermo Fisher Scientific. The TaqMan Array Cards (TAC) are the only product that can be used for the spotting of reagents on 384 well cards which will be used for multi-pathogen testing of post-mortem specimens from enrolled cases in the Child Health and Mortality Prevention Surveillance (CHAMPS) program. The TACs are microfluidic arrays containing

20-40 CDC-developed PCR assays in customized configurations. This technology has been used by CDC for over 15 years, and evaluations of lab-created and clinical specimens have demonstrated that TAC has similar sensitivity and specificity to individual PCR reactions, but allows for higher throughput, reduced potential for contamination, lower cost, specimen conservation, and substantial improvement in ease of use for operator. Based on successful use of this product for other surveillance projects, it was selected for use in the Child Health and Morality Prevention Surveillance (CHAMPS) program. Going forward continued use of this product is required for continuity of specimen testing in accordance with CHAMPS program-specific protocols and funding.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at uid1@cdc.gov.
Active Contract Opportunity
Notice ID : 2023-76751
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office : CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 03, 2023 12:44 pm EDT
Original Response Date: Aug 10, 2023 03:00 pm EDT
Inactive Policy: Manual
Original Inactive Date: Aug 10, 2023
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Atlanta, GA 30329 USA

Documents

 Tender Notice

SSJ-for-NOI.pdf